Identification of carbapenem - resistant Acinetobacter calcoaceticus - Acinetobacter baumannii complex in ready-to-eat vegetables and meats in Hanoi

Types and prevalence of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in Northern Taiwan.

The frequency of the carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CRACB) complex increases annually in our hospitals. However, the types and prevalence of carbapenemases among isolates still remain unclear. In this study, we identified and collected 672 carbapenem-resistant isolates from a medical center in Northern Taiwan between April and December of 2010. There w...

Carbapenem-resistant Acinetobacter baumannii

To the editor: We read with interest the paper of Hrabák et al. [1] on the isolation of a blaNDM-1-carrying Acinetobacter baumannii strain. However, although the authors believed to be the first in the Czech Republic to report on a New Delhi metallo-beta-lactamase-1 (NDM-1)-producing bacterium, there have been other reports on the same A. baumannii strain in the country [2,3]. Here, we would li...

Types and Prevalence of Carbapenem - Resistant Acinetobacter 1 calcoaceticus - Acinetobacter baumannii Complex in Northern 2 Taiwan 3 4

Defining resistance in Acinetobacter calcoaceticus-Acinetobacter baumannii complex strains.

We read with great interest the recent publication of Tien and colleagues in which they describe the antimicrobial susceptibilities of a large number of Acinetobacter baumannii-Acinetobacter calcoaceticus strains isolated from a medical center in Taiwan (1). They suggested that antimicrobial susceptibility was negatively associated with virulent potential because more-susceptible strains were r...

Carbapenem-resistant Acinetobacter baumannii in healthcare settings

Carbapenem-resistant A. baumannii poses a significant threat to patients and healthcare systems in all EU/EEA countries. A. baumannii is the cause of serious infections in healthcare settings, and carbapenem resistance limits treatment options and increases the risk for adverse outcomes for patients. The epidemiological situation in Europe has worsened in the past years, with a higher number of...